ArticleInvestigational new drugs2015

Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer.

Jordi Rodón et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.